Development of a new screening assay to identify proteratogenic substances using zebrafish danio rerio embryo combined with an exogenous mammalian metabolic activation system (mDarT).
about
Transient overexpression of adh8a increases allyl alcohol toxicity in zebrafish embryosComparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery.Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Evaluation of embryotoxicity using the zebrafish modelDevelopmental toxicity of dextromethorphan in zebrafish embryos/larvae.Biocompatibility and biodistribution of functionalized carbon nano-onions (f-CNOs) in a vertebrate model.Zebrafish embryos and larvae: a new generation of disease models and drug screens.Zebrafish: as an integrative model for twenty-first century toxicity testing.Toward in vitro biomarkers for developmental toxicity and their extrapolation to the in vivo situation.Alternative Models of Developmental and Reproductive Toxicity in Pharmaceutical Risk Assessment and the 3Rs.G2-S16 dendrimer as a candidate for a microbicide to prevent HIV-1 infection in women.Optimization and Performance Assessment of the Chorion-Off [Dechorinated] Zebrafish Developmental Toxicity Assay.Oxidative stress-mediated developmental toxicity induced by isoniazide in zebrafish embryos and larvae.A Developmental Toxicology Assay Platform for Screening Teratogenic Liability of Pharmaceutical Compounds.Klippel-Feil syndrome in a boy exposed inadvertently to cyclophosphamide during pregnancy: a case report.Evaluation of Embryotoxicity Using the Zebrafish Model.
P2860
Q27317252-53D24A6E-8568-4FEF-B296-AF75C476B313Q34094154-806861D1-2607-4F7B-9D05-41B9BBC9D2BDQ34181630-4EB13E81-F2EB-4808-AEE0-F2F5AE76F4BBQ35140778-5E11F85C-6D02-48CD-9BF6-2B8192E980F3Q36449529-2F51F7A8-B014-401A-A1EE-C2FA4D52734AQ37285284-C33F86F3-DE2A-4E7E-9D5A-AA0002E0D9D0Q37889217-FE75BF21-A84A-46C6-AC17-DB0AAB08BDDFQ37935725-1EE36685-FAB5-4FB1-BA0B-80B4B3E9F6E2Q37960551-5FF6B2EE-DA86-4474-984C-6DA1E17E8036Q38774778-FCF5D303-3580-424D-B7CE-7319805FACC5Q40135804-FE0057EF-E792-4F71-813C-82071ED20D85Q41068239-4C4E4EC0-1EFD-46C4-8A6E-AC3BF1A31B78Q46425509-1288919F-B58A-4588-88ED-142B79125BE9Q50541710-370D7B00-3061-414C-A1E5-DC6121954A8EQ51799336-F0A96BEC-F62B-4840-B39B-846041563831Q53565972-2E6E4E6E-7E3B-44FB-9597-34CE2828D525
P2860
Development of a new screening assay to identify proteratogenic substances using zebrafish danio rerio embryo combined with an exogenous mammalian metabolic activation system (mDarT).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Development of a new screening ...... lic activation system (mDarT).
@en
Development of a new screening ...... an metabolic activation system
@nl
type
label
Development of a new screening ...... lic activation system (mDarT).
@en
Development of a new screening ...... an metabolic activation system
@nl
prefLabel
Development of a new screening ...... lic activation system (mDarT).
@en
Development of a new screening ...... an metabolic activation system
@nl
P2093
P356
P1476
Development of a new screening ...... lic activation system (mDarT).
@en
P2093
François Busquet
Friedrich von Landenberg
Nicole Huebler
Roland Nagel
Stefan O Mueller
Thomas H Broschard
P304
P356
10.1093/TOXSCI/KFN065
P577
2008-03-28T00:00:00Z